New York Crohn’s and Colitis Organization
To further collaborative clinical and translational research opportunities among Inflammatory Bowel Disease (IBD) clinicians in the New York Area
To advance the care of IBD patients and nurture cooperation amongst IBD clinicians
To mentor junior investigators and further promote their education in the field of IBD
NYCCO Publications and Meeting Abstracts
Axelrad JE, Bazarbashi AN, Zhou J, Castañeda D, Gujral A, Sperling D, Glass J, Agrawal M, Hong S, Lawlor G, Hudesman D, Chang S, Shah S, Khalili H, Ananthakrishnan A, Colombel JF, Itzkowitz S; New York Crohn’s and Colitis Organization (NYCCO). Hormone Therapy for Cancer is a Risk Factor for Relapse of Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2020 Apr;18(4):872-880
Agrawal M, Cohen-Mekelburg S, Kayal M, Axelrad J, Galati J, Tricomi B, Kamal K, Faye, A, Abrudescu P, Scherl E, Lawlor G, Sultan K, Lukin D, Columbel JF, Ungaro R. Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio-economic factors. Aliment Pharmacol Ther. 2019 Mar;49(5):564-571. doi: 10.1111/apt.15107.
Ungaro R, Fausel R, Chang HL, Chang S, Chen LA, Nakad A, El Nawar A, Prytz Berset I, Axelrad J, Lawlor G, Atreja A, Roque Ramos L, Torres J, Colombel JF. Bariatric surgery is associated with increased risk of new-onset inflammatory bowel disease: case series and national database study Aliment Pharmacol Ther. 2018 Apr;47(8):1126-1134
Axelrad J, Bernheim O, Colombel JF, Malerba S, Ananthakrishnan A, Yajnik, Hoffman G, Agrawal M, Lukin D, Desai A, Mceachern E, Bosworth B, Scherl E, Reyes A, Zaidi H, Mudireddy P, DiCaprio D, Sultan K, Korelitz B, Wang E, Williams R, Chen L, Katz S, Itzkowitz S. Risk of new or recurrent cancer in patients with inflammatory bowel disease and previous cancer exposed to immunosuppressive and anti-tumor necrosis factor agents. Clin Gastroenterol Hepatol 2016;14:58-64.
Recent Meeting Presentations:
Kassim, Gassan MD1; Debebe, Anketse PhD1; Cholapranee, Aurada MD2; Sultan, Keith MD3; Colombel, Jean-Frederic1; Sachar, David B. MD, MACG1 S0798 Long-Term Outcomes of the Excluded Rectum in Crohn’s Disease – Results From the CAPER (Consortium to Assess Prognosis of the Excluded Rectum) Study, The American Journal of Gastroenterology: October 2020 - Volume 115 - Issue - p S409 doi: 10.14309/01.ajg.0000705240.29218.7e
Castillo G, Guttentag A, Kwah J, Al-Ani A, Sharma B, Chen LA, Sultan K, Axelrad JE. Induction With Biologic Therapy Improves Disability From Inflammatory Bowel Disease. Poster presentation at virtual American College of Gastroenterology Annual Meeting October 2020.
Castillo G, Guttentag A, Kwah J, Al-Ani A, Sharma B, Chen LA, Sultan K, Axelrad JE. Sexual Dysfunction Correlates With Disease Activity, Quality of Life Metrics, and Improves After Induction With Biologic Therapy. Poster presentation at virtual American College of Gastroenterology Annual Meeting October 2020.
Yzet, Clara; Kassim, Gassan; Nair, Nilendra ,Colombel, Jean-Frederic; Sachar, David. Long-term fate of the excluded rectum in Crohn’s disease. Presented at the European Crohn's and Colitis Organisation - IBD 14th Congress (ECCO)Copenhagen, Denmark March 2019
Axelrad J, Bazarbashi AN, Zhou J, Glass J, Agrawal M, Hong S, Lawlor G, Lichtiger S, Chang S, Colombel JF, Itzkowitz S. Hormone Therapy for Cancer is a Risk Factor for IBD Reactivation. Poster presentation at Digestive Disease Week, 3 June 2018, Washington D.C.
Leung G, Faleck D, Colombel JF, Dubinsky M, Berkowitz J, Sultan K, Axelrad J, Cohen M, Lawlor G, Agrawal M, Lukin D, Katz S, Chen LA. Infliximab Re-introduction after Temporary Discontinuation: a multicentric survey. Gastroenterol. 2017;152(5);S400.